Methofill

Methotrexate, the active ingredient in Methofill, is an antimetabolite presented as a subcutaneous injection for systemic use. It is employed to manage autoimmune disorders, certain malignancies, and ectopic pregnancy, acting as an immunosuppressant and cytotoxic agent in adult and pediatric patients as appropriate. The formulation is designed for subcutaneous delivery, allowing steady absorption and convenient administration in clinical settings.

GNH USA supplies Methofill as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide through its global network.

Methofill (methotrexate) acts on rapidly dividing cells and immune pathways, providing therapeutic benefit in several disease categories. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: decreases skin cell proliferation and improves plaque lesions. - Acute lymphoblastic leukemia: interferes with cancer cell DNA synthesis, contributing to remission. - Non‑Hodgkin lymphoma: impedes malignant lymphocyte growth as part of chemotherapy regimens. - Ectopic pregnancy: terminates trophoblastic tissue to avoid surgical intervention.

Methofill may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Fatigue: persistent tiredness affecting daily activities. - Mouth sores: ulceration of oral mucosa. - Low blood counts: mild leukopenia or anemia.

Serious or Rare Side Effects: - Severe liver toxicity: marked elevation of transaminases or hepatitis. - Pulmonary fibrosis: progressive shortness of breath and interstitial lung disease. - Bone marrow failure: pancytopenia requiring medical intervention.

When using Methofill, several safety measures and monitoring practices should be observed. - Monitor blood counts: perform regular CBC tests to detect cytopenias early. - Assess liver function: schedule periodic LFTs to identify hepatotoxicity. - Evaluate renal function: check serum creatinine and clearance before dosing. - Avoid live vaccines: immunosuppression increases infection risk from live attenuated vaccines. - Counsel on contraception: pregnancy is contraindicated; effective birth control must be used. - Store at room temperature: keep in original container, protect from moisture and light.

Methofill can interact with other medicines, altering its efficacy or toxicity profile.

Major Interactions (Avoid): - NSAIDs: may increase risk of renal impairment and reduce methotrexate clearance. - Trimethoprim‑sulfamethoxazole: enhances myelosuppression and can cause severe cytopenias. - Live vaccines: heightened risk of infection due to combined immunosuppression.

Moderate Interactions (Monitor Closely): - Azathioprine: additive immunosuppressive effect may require dose adjustments. - Proton pump inhibitors: may affect methotrexate absorption and increase serum levels.